Further evidence for the use of aspirin in COVID-19.
Publication
, Journal Article
Tantry, US; Bliden, KP; Gurbel, PA
Published in: Int J Cardiol
January 1, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Int J Cardiol
DOI
EISSN
1874-1754
Publication Date
January 1, 2022
Volume
346
Start / End Page
107 / 108
Location
Netherlands
Related Subject Headings
- SARS-CoV-2
- Humans
- Cardiovascular System & Hematology
- COVID-19
- Aspirin
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., Bliden, K. P., & Gurbel, P. A. (2022). Further evidence for the use of aspirin in COVID-19. Int J Cardiol, 346, 107–108. https://doi.org/10.1016/j.ijcard.2021.11.021
Tantry, Udaya S., Kevin P. Bliden, and Paul A. Gurbel. “Further evidence for the use of aspirin in COVID-19.” Int J Cardiol 346 (January 1, 2022): 107–8. https://doi.org/10.1016/j.ijcard.2021.11.021.
Tantry US, Bliden KP, Gurbel PA. Further evidence for the use of aspirin in COVID-19. Int J Cardiol. 2022 Jan 1;346:107–8.
Tantry, Udaya S., et al. “Further evidence for the use of aspirin in COVID-19.” Int J Cardiol, vol. 346, Jan. 2022, pp. 107–08. Pubmed, doi:10.1016/j.ijcard.2021.11.021.
Tantry US, Bliden KP, Gurbel PA. Further evidence for the use of aspirin in COVID-19. Int J Cardiol. 2022 Jan 1;346:107–108.
Published In
Int J Cardiol
DOI
EISSN
1874-1754
Publication Date
January 1, 2022
Volume
346
Start / End Page
107 / 108
Location
Netherlands
Related Subject Headings
- SARS-CoV-2
- Humans
- Cardiovascular System & Hematology
- COVID-19
- Aspirin
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology